170270 ⎘
Assays involving biological materials from specific organisms or of a specific nature from viruses; RNA viruses; Togaviridae; Flaviviridae; Flaviviridae, e.g. pestivirus, mucosal disease virus, bovine viral diarrhoea virus, classical swine fever virus (hog cholera virus) or border disease virus Hepatitis C; Hepatitis NANB
Sexually Transmitted Infection Testing from Human Dried Blood Spots Collected Remotely
#2HCV ANTIGENS AND ANTIBODIES
#3AFFINITY PARTICLE, TEST REAGENT, AND DETECTION METHOD FOR DETECTING TARGET IMMUNOGLOBULIN G IN HUMAN SPECIMEN
#4NOVEL HCV NUCLEIC ACIDS AND ENCODED GLYCOPROTEIN ANTIGENS AND METHODS
#5Electrophoretic Bar Code Assay Devices and Methods for Making and Using the Same
#6HCV Recombinant Antigen and Application
#7HCV Recombinant Antigen and Mutant thereof
#8EXOSOME-MEDIATED DIAGNOSIS OF HEPATITIS VIRUS INFECTIONS AND DISEASES
#9Method of detecting antibodies against JEV or ZIKV using recombinant baculoviruses expressing prM/e
#10ELECTROPHORETIC BAR CODE ASSAY DEVICES AND METHODS FOR MAKING AND USING THE SAME
#11SAMPLE PRETREATMENT METHOD FOR VIRUS DETECTION
#12Detection methods employing HCV core lipid and DNA binding domain monoclonal antibodies
#13Subject anti-HCV antibody detection assays employing NS3 capture peptides
#14RECOMBINANT BACULOVIRUSES AND THEIR USES IN DETECTING ARTHROPOD-BORNE VIRUS
#15Multi-epitope fusion protein of an HCV antigen and uses thereof
#16DETECTION METHODS EMPLOYING HCV CORE LIPID AND DNA BINDING DOMAIN MONOCLONAL ANTIBODIES
#17DETECTION METHODS EMPLOYING HCV CORE LIPID AND DNA BINDING DOMAIN MONOCLONAL ANTIBODIES
#18Exosome-mediated diagnosis of human immunodeficiency virus infection
#19Exosome-mediated diagnosis of hepatitis virus infections and diseases
#20Immunoassay using at least two pegylated analyte-specific binding agents
#21Neutralizing human monoclonal antibody 8D6 against HCV infection
#22VIRUS INFECTION MODEL, PREPARATION METHOD THEREFOR, AND UTILIZATION THEREOF
#23HCV NS4a/modified NS3 polypeptides and uses thereof
#24Recombinant baculoviruses and their uses in detecting arthropod-borne virus
#25HCV core and minicore binding molecules
#26Method and system for detection of disease agents in blood
#27Subject anti-HCV antibody detection assays employing NS3 capture peptides
#28CAMELID SINGLE-DOMAIN HCV ANTIBODIES AND METHODS OF USE
#29Reagents for HCV antigen-antibody combination assays
#30Employing human adipose-derived stem cells to propagate serum-derived hepatitis C virus and use thereof
#31HCV NS4A/modified NS3 polypeptides and uses thereof
#32Method for detecting an infection by the hepatitis C virus
#33Method and system for detection of disease agents in blood
#34Compositions and cell-based methods for monitoring the activity of a Dengue Virus protease
#35Exosome-mediated diagnosis of hepatitis virus infections and diseases
#36Detection methods employing HCV core lipid and DNA binding domain monoclonal antibodies
#37Detection methods employing HCV core lipid and DNA binding domain monoclonal antibodies
#38PROGNOSTIC KITS, ARRAYS COMPOSITIONS AND METHODS FOR PREDICTING INTERFERON TREATMENT EFFICACY IN A SUBJECT
#39Exosome-mediated diagnosis of hepatitis virus infections and diseases
#40HCV antigen-antibody combination assay and methods and compositions for use therein
#41HCV core lipid binding domain monoclonal antibodies
#422′-branched nucleosides and flaviviridae mutation
#43Subject anti-HCV antibody detection assays employing NS3 capture peptides
#44HCV ANTIGEN-ANTIBODY COMBINATION ASSAY AND METHODS AND COMPOSITIONS FOR USE THEREIN
#45Compositions and methods for simultaneous detection of HCV antigen/antibody
#46Reagents for HCV antigen-antibody combination assays
#47Compositions and methods for identifying enzyme and transport protein inhibitors
#48COMPOSITIONS AND METHODS FOR DETECTION OF A TARGET IN A MOLECULAR ASSAY USING PH CHANGES
#49METHODS AND KITS FOR THE DETECTION OF VIRAL INFECTIONS
#50Electrophoretic bar code assay devices and methods for making and using the same
#51Protein microarray for characterizing the specificity of the monoclonal immunoglobulins of MGUS or myeloma patients
#52Combination hepatitis C virus antigen and antibody detection method
#53Peptides derived from viral proteins for use as immunogens and dosage reactants
#54Hepatitis C virus neutralizing antibody
#55Method for detecting an infection by the hepatitis C virus
#56METHOD FOR IDENTIFYING MARKERS
#57Mutant replicon derived from genome of hepatitis C virus J6CF strain
#58Nucleic acid construct comprising nucleic acid derived from genome of hepatitis C virus of genotype 3a
#59Molecules inhibiting a metabolic pathway involving the Syk protein tyrosine kinase and method for identifying said molecules
#60Compositions and methods
#61HCV genotype 4 replicons
#62HCV genotype 3 replicons
#63ANTI-VIRAL THERAPY
#64INDIRECTLY LABELLED ASSAY CONJUGATES AND METHODS OF PREPARING AND USING SAME
#65Materials and methods for assay of anti-hepatitis C virus (HCV) antibodies
#66HUMAN HCV-INTERACTING PROTEINS AND METHODS OF USE
#67Method for Drug Screening For Agents for the Treatment of Hepatitis C Virus Infection
#68Compositions and methods for identifying enzyme and transport protein inhibitors
#69Method for identifying protease inhibitors
#70Solid Support for HCV Detection
#71BIOMARKERS FOR PREDICTING SUSTAINED RESPONSE TO HCV TREATMENT
#72DETECTION OF IFI16 IN BODY FLUIDS
#73Hepatitis-C virus testing
#74BIOMARKERS FOR PREDICTING RAPID RESPONSE TO HCV TREATMENT
#75HCV entry factor, Occludin
#76Host cell kinases as targets for antiviral therapies against HCV infection
#77CELL CAPABLE OF REPLICATING NOVEL HCV REPLICON, CELL CAPABLE OF REPLICATING FULL-LENGTH HCV RNA, AND USE OF THOSE CELLS
#782′-branched nucleosides and mutation
#79MOLECULES INHIBITING A METABOLIC PATHWAY INVOLVING THE SYK PROTEIN TYROSINE KINASE AND METHOD FOR IDENTIFYING SAID MOLECULES
#80Methods for Screening Compounds for Treating and/or Preventing an Hepatitis C Virus Infection
#81Methods of treating a family viral infection and compositions for treating a family viral infection
#82Hepatitis C virus antibodies
#83Reagents For HCV Antigen-Antibody Combination Assays
#84ANTIBODY HAVING INHIBITORY ACTIVITY ON INFECTION WITH HEPATITIS C VIRUS (HCV) AND USE THEREOF
#85INDIRECTLY LABELLED ASSAY CONJUGATES AND METHODS OF PREPARING AND USING SAME
#86Hepatitis-C virus testing
#87Methods of treating a flaviviridae family viral infection, compositions for treating a flaviviridae family viral infection, and screening assays for identifying compositions for treating a flaviviridae family viral infection
#88Tissue culture system for production of hepatitis C virus
#89Method for identifying protease inhibitors
#90EFFICIENTLY REPLICABLE HEPTITIS C VIRUS MUTANT, A HEPTITIS C VIRUS MUTANT COMPRISING REPORTER GENE, A METHOD OF PREPARING OF HCV VACCINE USING THE SAME AND A METHOD OF SCREENING ANTI HCV COMPOSITION USING THE SAME
#91HCV GENE
#92Methods and composition of treating a flaviviridae family viral infection
#93Methods and compositions of treating a family viral infection
#94METHOD FOR DETECTING A VIRUS
#95INDIRECTLY LABELLED ASSAY CONJUGATES AND METHODS OF PREPARING AND USING SAME
#96NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION
#97Methods for the production of HCV, assaying HCV entry, and screening drugs and cellular receptors for HCV
#98Methods and compositions for identifying anti-HCV agents
#99Method for identifying markers
#100Combination hepatitis C virus antigen and antibody detection method
#101Hepatitis-C virus testing
#102Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins
#103Method for identifying markers
#1042′-branched nucleosides and Flaviviridae mutation